These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31842451)

  • 1. 3-Substituted 1-Naphthamidomethyl-C-galactosyls Interact with Two Unique Sub-sites for High-Affinity and High-Selectivity Inhibition of Galectin-3.
    Dahlqvist A; Mandal S; Peterson K; Håkansson M; Logan DT; Zetterberg FR; Leffler H; Nilsson UJ
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31842451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based development of triazole-substituted O-galactosyl aldoximes with fragment-induced affinity and selectivity for galectin-3.
    Tejler J; Salameh B; Leffler H; Nilsson UJ
    Org Biomol Chem; 2009 Oct; 7(19):3982-90. PubMed ID: 19763301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.
    Oberg CT; Blanchard H; Leffler H; Nilsson UJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3691-4. PubMed ID: 18539029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and thermodynamic studies on cation-Pi interactions in lectin-ligand complexes: high-affinity galectin-3 inhibitors through fine-tuning of an arginine-arene interaction.
    Sörme P; Arnoux P; Kahl-Knutsson B; Leffler H; Rini JM; Nilsson UJ
    J Am Chem Soc; 2005 Feb; 127(6):1737-43. PubMed ID: 15701008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain.
    Pal KB; Mahanti M; Huang X; Persson S; Sundin AP; Zetterberg FR; Oredsson S; Leffler H; Nilsson UJ
    Org Biomol Chem; 2018 Aug; 16(34):6295-6305. PubMed ID: 30117507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.
    Peterson K; Kumar R; Stenström O; Verma P; Verma PR; Håkansson M; Kahl-Knutsson B; Zetterberg F; Leffler H; Akke M; Logan DT; Nilsson UJ
    J Med Chem; 2018 Feb; 61(3):1164-1175. PubMed ID: 29284090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3.
    Henrick K; Bawumia S; Barboni EA; Mehul B; Hughes RC
    Glycobiology; 1998 Jan; 8(1):45-57. PubMed ID: 9451013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regioselective 3-O-Substitution of Unprotected Thiodigalactosides: Direct Route to Galectin Inhibitors.
    Vašíček T; Spiwok V; Červený J; Petrásková L; Bumba L; Vrbata D; Pelantová H; Křen V; Bojarová P
    Chemistry; 2020 Aug; 26(43):9620-9631. PubMed ID: 32368810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic synthesis of non-natural trisaccharides and galactosides; Insights of their interaction with galectins as a function of their structure.
    Porciúncula González C; Cagnoni AJ; Mariño KV; Fontana C; Saenz-Méndez P; Irazoqui G; Giacomini C
    Carbohydr Res; 2019 Jan; 472():1-15. PubMed ID: 30428394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Galectin-8N Ligands: The Design and Synthesis of Phthalazinone-d-Galactals.
    van Klaveren S; Sundin AP; Jakopin Ž; Anderluh M; Leffler H; Nilsson UJ; Tomašič T
    ChemMedChem; 2022 Mar; 17(6):e202100575. PubMed ID: 34913595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors.
    Hsieh TJ; Lin HY; Tu Z; Lin TC; Wu SC; Tseng YY; Liu FT; Hsu ST; Lin CH
    Sci Rep; 2016 Jul; 6():29457. PubMed ID: 27416897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactulose as a novel template for anticancer drug development targeting galectins.
    Kishor C; Ross RL; Blanchard H
    Chem Biol Drug Des; 2018 Oct; 92(4):1801-1808. PubMed ID: 29888844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of O-galactosyl aldoximes as potent LacNAc-mimetic galectin-3 inhibitors.
    Tejler J; Leffler H; Nilsson UJ
    Bioorg Med Chem Lett; 2005 May; 15(9):2343-5. PubMed ID: 15837322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Based Design of a Monosaccharide Ligand Targeting Galectin-8.
    Bohari MH; Yu X; Kishor C; Patel B; Go RM; Eslampanah Seyedi HA; Vinik Y; Grice ID; Zick Y; Blanchard H
    ChemMedChem; 2018 Aug; 13(16):1664-1672. PubMed ID: 29926535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of galactose-mimicking 1H-(1,2,3-triazol-1-yl)-mannosides as selective galectin-3 and 9N inhibitors.
    Tejler J; Skogman F; Leffler H; Nilsson UJ
    Carbohydr Res; 2007 Sep; 342(12-13):1869-75. PubMed ID: 17407769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
    Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
    Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.
    Salameh BA; Cumpstey I; Sundin A; Leffler H; Nilsson UJ
    Bioorg Med Chem; 2010 Jul; 18(14):5367-78. PubMed ID: 20538469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taloside inhibitors of galectin-1 and galectin-3.
    Collins PM; Oberg CT; Leffler H; Nilsson UJ; Blanchard H
    Chem Biol Drug Des; 2012 Mar; 79(3):339-46. PubMed ID: 22136701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear triazole-linked pseudo oligogalactosides as scaffolds for galectin inhibitor development.
    Dussouy C; Kishor C; Lambert A; Lamoureux C; Blanchard H; Grandjean C
    Chem Biol Drug Des; 2020 Oct; 96(4):1123-1133. PubMed ID: 32220037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human galectin-3 selective and high affinity inhibitors. Present state and future perspectives.
    Téllez-Sanz R; García-Fuentes L; Vargas-Berenguel A
    Curr Med Chem; 2013; 20(24):2979-90. PubMed ID: 23834183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.